Life Sciences Photonics R&D

We believe Life Sciences applications, with their world-wide markets and strong benefits to society, offer the largest potential for G&H’s expansion. G&H is the established leader in fiber optical subsystems for Optical Coherence Tomography (OCT), which has now become the standard ophthalmic diagnostic tool and is being deployed into multiple other applications like cardio and cancer imaging.

We are investing in R&D and applications engineering, new products and new capabilities specifically targeted at biomedical applications. One of our leading initiatives to demonstrate the potential of our photonics components, and our ability to create complete system solutions is our prototype system for Hyper Spectral Imaging Cervical Cancer Diagnostics.

G&H is passionate about developing new photonics technology for Life Sciences. Let us know what your application is and we can see how we can support you.

Current funded, collaborative research programs include:

minerva3a_smallerMINERVA, aims to develop photonic technology in the mid-IR to improve early cancer detection.